{"transactions":[{"id":797127,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50621,"kind":"person","name":"Anderman Jonathan","position":1,"cik":"0002032625","reported_name":"Anderman Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-04-30T16:00:25.000Z","date":"2026-04-29","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.89,"value":47250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"150,000 of the shares represents unvested restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027."}],"balance_after":196000,"source":{"system":"sec-edgar","filing":"0001171843-26-002893","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032625/000117184326002893/ownership.xml","form_type":"4/A","original_submission_date":"2026-04-29"}},{"id":798098,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50621,"kind":"person","name":"Anderman Jonathan","position":1,"cik":"0002032625","reported_name":"Anderman Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-04-29T21:11:59.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":1.89,"value":47250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"150,000 of the shares represents unvested restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027."}],"balance_after":196000,"source":{"system":"sec-edgar","filing":"0001171843-26-002840","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032625/000117184326002840/ownership.xml","form_type":"4"}},{"id":952272,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50621,"kind":"person","name":"Anderman Jonathan","position":1,"cik":"0002032625","reported_name":"Anderman Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-05T21:32:06.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":720000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest over 48 substantially equal monthly installments starting February 2, 2026."}],"balance_after":720000,"derivative":{"exercise_price":5.17,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":720000},"source":{"system":"sec-edgar","filing":"0001171843-26-000051","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2032625/000117184326000051/ownership.xml","form_type":"4"}},{"id":952271,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50621,"kind":"person","name":"Anderman Jonathan","position":1,"cik":"0002032625","reported_name":"Anderman Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2026-01-05T21:32:06.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":5.17,"value":775500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first vesting on January 2, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"150,000 of the shares represents unvested restricted stock units (\"RSU\") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027."}],"balance_after":171000,"source":{"system":"sec-edgar","filing":"0001171843-26-000051","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032625/000117184326000051/ownership.xml","form_type":"4"}},{"id":1175811,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50621,"kind":"person","name":"Anderman Jonathan","position":1,"cik":"0002032625","reported_name":"Anderman Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Gen Counsel & Corporate Sec"}}],"security":"Common Stock","published_at":"2025-04-08T13:30:55.000Z","date":"2025-04-07","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.54,"value":30800.0,"ownership":{"direct":true},"balance_after":21000,"source":{"system":"sec-edgar","filing":"0001171843-25-002086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032625/000117184325002086/ownership.xml","form_type":"4"}},{"id":1269922,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50621,"kind":"person","name":"Anderman Jonathan","position":1,"cik":"0002032625","reported_name":"Anderman Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Gen Counsel & Corp Sec"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T22:09:27.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting March 11, 2025."}],"balance_after":280000,"derivative":{"exercise_price":3.65,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001171843-25-000825","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032625/000117184325000825/ownership.xml","form_type":"4"}},{"id":1433988,"issuer":{"id":5614,"kind":"organization","name":"Compass Therapeutics, Inc.","symbol":"CMPX"},"owners":[{"id":50621,"kind":"person","name":"Anderman Jonathan","position":1,"cik":"0002032625","reported_name":"Anderman Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr VP, Gen Counsel & Corp Sec"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T12:49:46.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over 48 substantially equal monthly installments starting September 13, 2024."}],"balance_after":300000,"derivative":{"exercise_price":1.2,"expiration_date":"2034-08-13","underlying":"CommonStock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001171843-24-004782","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2032625/000117184324004782/ownership.xml","form_type":"4"}}]}